Paper37397366
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.
Torres-Sanchez A and 5 others. Front Oncol, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models. Papers, record 37397366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37397366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20 GM103475 | NIGMS NIH HHS | United States | P20GM103475 | PubMed and NIH | NIH RePORTER |
| R25 GM061838 | NIGMS NIH HHS | United States | R25GM061838 | PubMed | NIH RePORTER |
| R16 GM149427 | NIGMS NIH HHS | United States | R16GM149427 | PubMed and NIH | NIH RePORTER |
| R25 GM061151 | NIGMS NIH HHS | United States | R25GM061151 | PubMed | NIH RePORTER |
| SC3 GM084824 | NIGMS NIH HHS | United States | SC3GM084824 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06075810 | A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer | Background |
Source ClinicalTrials.gov
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9050374 | Rho GTPases and leukocyte cytoskeletal regulation. | Curr Opin Hematol | 1997 | https://conductscience.org/library/papers/9050374 | PubMed |
| 2 | 28807941 | The Rac GTPase in Cancer: From Old Concepts to New Paradigms. | Cancer Res | 2017 | https://conductscience.org/library/papers/28807941 | PubMed |
| 3 | 25389450 | The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model. | Transl Oncol | 2014 | https://conductscience.org/library/papers/25389450 | PubMed |
| 4 | 34607932 | Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer. | Mol Cancer Ther | 2021 | https://conductscience.org/library/papers/34607932 | PubMed |
| 5 | 29976575 | IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. | Cancer Res | 2018 | https://conductscience.org/library/papers/29976575 | PubMed |
| 6 | 27376091 | Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes. | J Immunol Res | 2016 | https://conductscience.org/library/papers/27376091 | PubMed |
| 7 | 35537412 | Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35537412 | PubMed |
| 8 | 32445205 | Macrophage targeting in cancer. | Ann N Y Acad Sci | 2021 | https://conductscience.org/library/papers/32445205 | PubMed |
| 9 | 21965337 | Breast cancer stem cells, cytokine networks, and the tumor microenvironment. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21965337 | PubMed |
| 10 | 24875653 | Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/24875653 | PubMed |
| 11 | 31629410 | Tumor-associated macrophages: an accomplice in solid tumor progression. | J Biomed Sci | 2019 | https://conductscience.org/library/papers/31629410 | PubMed |
| 12 | 30065108 | The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic. | Biochem Soc Trans | 2018 | https://conductscience.org/library/papers/30065108 | PubMed |
| 13 | 31043378 | Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network. | Cancer Res | 2019 | https://conductscience.org/library/papers/31043378 | PubMed |
| 14 | 31720502 | Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography-Tandem Mass Spectrometry. | ACS Omega | 2019 | https://conductscience.org/library/papers/31720502 | PubMed |
| 15 | 31053634 | Defining the Hallmarks of Metastasis. | Cancer Res | 2019 | https://conductscience.org/library/papers/31053634 | PubMed |
| 16 | 26253167 | M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26253167 | PubMed |
| 17 | 24613573 | The IL-6 feed-forward loop: a driver of tumorigenesis. | Semin Immunol | 2014 | https://conductscience.org/library/papers/24613573 | PubMed |
| 18 | 33365025 | Tumor-Associated Macrophages in Tumor Immunity. | Front Immunol | 2020 | https://conductscience.org/library/papers/33365025 | PubMed |
| 19 | 29481824 | Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3. | Immunol Lett | 2018 | https://conductscience.org/library/papers/29481824 | PubMed |
| 20 | 28212753 | The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. | Mol Cell | 2017 | https://conductscience.org/library/papers/28212753 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856377 | Chemical proteomics reveals post-translational remodeling of endosomal pathways during macrophage activation. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856377 | PubMed |
| 42520352 | Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment. | Cancer Treat Res Commun | 2026 | https://conductscience.org/library/papers/42520352 | PubMed |
| 41663524 | Peripheral blood CD14 + monocytes in luminal breast carcinoma subtypes: in preliminary research and overview of candidate biomarker proteins. | Sci Rep | 2026 | https://conductscience.org/library/papers/41663524 | PubMed |
| 40723284 | Cancer-Associated Fibroblasts Establish Spatially Distinct Prognostic Niches in Subcutaneous Colorectal Cancer Mouse Model. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723284 | PubMed |
| 40689767 | Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus. | FASEB J | 2025 | https://conductscience.org/library/papers/40689767 | PubMed |
| 39104525 | Understanding tissue-resident macrophages unlocks the potential for novel combinatorial strategies in breast cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39104525 | PubMed |
| 39087451 | Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel. | Mol Cancer Ther | 2024 | https://conductscience.org/library/papers/39087451 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ARHGEF2 | 9181 | PubTator's text mining | https://conductscience.org/library/genes/9181 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CDC42 | 998 | PubTator's text mining | https://conductscience.org/library/genes/998 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| RAC1 | 5879 | PubTator's text mining | https://conductscience.org/library/genes/5879 | NCBI Gene |
| RAC2 | 5880 | PubTator's text mining | https://conductscience.org/library/genes/5880 | NCBI Gene |
| RHO | 6010 | PubTator's text mining | https://conductscience.org/library/genes/6010 | NCBI Gene |
| VAV1 | 7409 | PubTator's text mining | https://conductscience.org/library/genes/7409 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37397366
GET https://conductscience.org/api/papers/v1/37397366/references?page=2